Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis Location: Atlanta, Georgia 13 trials found
New Search
Filter
Trial Phase
Study Type
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
PHASE2INTERVENTIONAL Atlanta, Georgia +2 more
RECRUITING
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
PHASE4INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
NAINTERVENTIONAL Atlanta, Georgia
RECRUITING
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
EARLY_PHASE1INTERVENTIONAL Atlanta, Georgia +1 more
RECRUITING
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
NAINTERVENTIONAL Irvine, California +4 more
RECRUITING
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NAINTERVENTIONAL Atlanta, Georgia
RECRUITING
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
N/AOBSERVATIONAL San Francisco, California +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type